Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Oropharyngeal Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
14 drugs · 85 active trials
1 drug · 0 active trials
0 drugs · 0 active trials
no drug at this stage
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 14 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Temsirolimus | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2010-11 |
| Valproic Acid | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2012-09 |
| Veliparib | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | Oct 22, 2012 |
| Berzosertib | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Apr 17, 2017 |
| Camonsertib | Phase 1 | Phase 1 | 1 | 1 | 0 | 1 | 0 | — | — | Feb 13, 2027 |
| Elimusertib | Phase 1 | Phase 1 | 1 | 0 | 0 | 1 | 0 | — | — | Jul 6, 2022 |
| Everolimus | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2008-11 |
| Gefitinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2002-02 |
| Alvespimycin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2004-07 |
| Filgrastim | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2001-07 |
| Ganetespib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2014-12 |
| Lenalidomide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Feb 10, 2011 |
| Metformin | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Nov 1, 2018 |
| Onalespib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Oct 22, 2015 |
| Temoporfin | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | 2013-12 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.